Part of the MaRS Entrepreneurship 101 Event Series
"Hey buddy, can you spare a $100 million?"
OR: How to convince successful financiers to give you millions of dollars in a project doomed to fail!
Speaker: Mike Polonsky, Senior Vice President, The Equicom Group
Download the audio presentation and post questions on the MaRS blog:
http://blog.marsdd.com/2007/04/11/entrepreneurship-101-who-should-pitch/
Cytori CEO Chris Calhoun presents as part of the "Cardiovascular, AMI & PAD" panel on the Regenerative Medicine Insight Track at the Biotech Showcase on January 10, 2012
A Clinical Trial of CCR5 Inhibition in Treated HIV Infection: Highlighting Mu...CTSI at UCSF
A presentation by Peter W. Hunt, M.D., Assistant Professor in Residence at the University of California, San Francisco (UCSF), conducted at the San Francisco General Hospital (SFGH) and supported by CTSI's Clinical Research Services. Learn more about the service at http://ctsi.ucsf.edu/our-work/clinical-research-services
Cytori CEO Chris Calhoun presents as part of the "Cardiovascular, AMI & PAD" panel on the Regenerative Medicine Insight Track at the Biotech Showcase on January 10, 2012
A Clinical Trial of CCR5 Inhibition in Treated HIV Infection: Highlighting Mu...CTSI at UCSF
A presentation by Peter W. Hunt, M.D., Assistant Professor in Residence at the University of California, San Francisco (UCSF), conducted at the San Francisco General Hospital (SFGH) and supported by CTSI's Clinical Research Services. Learn more about the service at http://ctsi.ucsf.edu/our-work/clinical-research-services
MaRS BioEntrepreneurship Series Event, June 12, 2007
Speaker: Wayne Schnarr, Senior VP, Life Sciences, The EquicomGroup
More information including a video: http://www.marsdd.com/bioent/june12
This slide deck has been created for clinician use in creating presentations detailing Colorectal Cancer Liver Metastases, the Selective Internal Radiation Therapy (SIRT) procedure available to treat this condition, supported by the clinical data that supports this treatment and and ongoing RCT trials to further document the success of this treatment. This information maybe used in its entirety or in sections, according to the material being presented and the audience to which it will be used. The sections included in this slide deck are as follows:
Colorectal Cancer Liver Metastases (mCRC)
Overview Selective Internal Radiation Therapy (SIRT)
Overview SIR-Spheres(r) microspheres
Clinical Data in mCRC Ongoing Level 1 RCT for mCRC in the liver
di Mario Cazzola, Dipartimento di Medicina Molecolare, Università degli Studi di Pavia - Clinica Ematologica, Fondazione IRCCS Policlinico San Matteo, Pavia.
Slide per l'intervento tenuto in Fondazione Giannino Bassetti in occasione del primo incontro del ciclo "La medicina di precisione", primo progetto dalla convenzione tra Università di Pavia e Fondazione Bassetti.
12 marzo 2018
Bill Faloon at DaVinci 50 about stroke risk and blood pressuremaximuspeto
In this presentation on Thursday April 29th, 2021 at the DaVinci 50 Mastermind Conference in Key Largo, Florida, Bill Faloon discusses how to optimize blood pressure to reduce stroke risk.
Don Tapscott's New Solutions for a Connected Planet - MaRS Global LeadershipMaRS Discovery District
In this new age of networked intelligence, collaborative communities are enhancing and even bypassing crumbling institutions. We are innovating the way our financial institutions and governments operate; how we educate our children; how the healthcare, newspaper, and energy industries serve their customers; how we care for our neighbourhoods; and even how we solve global problems.
From his latest book, (co-author Anthony D. Williams) Macrowikinomics: New Solutions for a Connected Planet, Don Tapscott presents groundbreaking innovations from every corner of the globe: how businesses, organizations and individuals alike are using mass collaboration to revolutionize not only the way we work, but how we live, learn, create and care for each other.
MaRS BioEntrepreneurship Series Event, June 12, 2007
Speaker: Wayne Schnarr, Senior VP, Life Sciences, The EquicomGroup
More information including a video: http://www.marsdd.com/bioent/june12
This slide deck has been created for clinician use in creating presentations detailing Colorectal Cancer Liver Metastases, the Selective Internal Radiation Therapy (SIRT) procedure available to treat this condition, supported by the clinical data that supports this treatment and and ongoing RCT trials to further document the success of this treatment. This information maybe used in its entirety or in sections, according to the material being presented and the audience to which it will be used. The sections included in this slide deck are as follows:
Colorectal Cancer Liver Metastases (mCRC)
Overview Selective Internal Radiation Therapy (SIRT)
Overview SIR-Spheres(r) microspheres
Clinical Data in mCRC Ongoing Level 1 RCT for mCRC in the liver
di Mario Cazzola, Dipartimento di Medicina Molecolare, Università degli Studi di Pavia - Clinica Ematologica, Fondazione IRCCS Policlinico San Matteo, Pavia.
Slide per l'intervento tenuto in Fondazione Giannino Bassetti in occasione del primo incontro del ciclo "La medicina di precisione", primo progetto dalla convenzione tra Università di Pavia e Fondazione Bassetti.
12 marzo 2018
Bill Faloon at DaVinci 50 about stroke risk and blood pressuremaximuspeto
In this presentation on Thursday April 29th, 2021 at the DaVinci 50 Mastermind Conference in Key Largo, Florida, Bill Faloon discusses how to optimize blood pressure to reduce stroke risk.
Don Tapscott's New Solutions for a Connected Planet - MaRS Global LeadershipMaRS Discovery District
In this new age of networked intelligence, collaborative communities are enhancing and even bypassing crumbling institutions. We are innovating the way our financial institutions and governments operate; how we educate our children; how the healthcare, newspaper, and energy industries serve their customers; how we care for our neighbourhoods; and even how we solve global problems.
From his latest book, (co-author Anthony D. Williams) Macrowikinomics: New Solutions for a Connected Planet, Don Tapscott presents groundbreaking innovations from every corner of the globe: how businesses, organizations and individuals alike are using mass collaboration to revolutionize not only the way we work, but how we live, learn, create and care for each other.
SR&ED: What you need to know about the changing landscape - MaRS Best PracticesMaRS Discovery District
The Scientific Research and Experimental Development (SR&ED) tax incentive program provides support in the form of tax credits to groups or individuals conducting scientific research or experimental development in Canada.
Some significant changes are on the way as a result of the last federal budget. See how these new rules could affect you!
Abhay Bhutada Leads Poonawalla Fincorp To Record Low NPA And Unprecedented Gr...Vighnesh Shashtri
Under the leadership of Abhay Bhutada, Poonawalla Fincorp has achieved record-low Non-Performing Assets (NPA) and witnessed unprecedented growth. Bhutada's strategic vision and effective management have significantly enhanced the company's financial health, showcasing a robust performance in the financial sector. This achievement underscores the company's resilience and ability to thrive in a competitive market, setting a new benchmark for operational excellence in the industry.
how to swap pi coins to foreign currency withdrawable.DOT TECH
As of my last update, Pi is still in the testing phase and is not tradable on any exchanges.
However, Pi Network has announced plans to launch its Testnet and Mainnet in the future, which may include listing Pi on exchanges.
The current method for selling pi coins involves exchanging them with a pi vendor who purchases pi coins for investment reasons.
If you want to sell your pi coins, reach out to a pi vendor and sell them to anyone looking to sell pi coins from any country around the globe.
Below is the contact information for my personal pi vendor.
Telegram: @Pi_vendor_247
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
Seminar: Gender Board Diversity through Ownership NetworksGRAPE
Seminar on gender diversity spillovers through ownership networks at FAME|GRAPE. Presenting novel research. Studies in economics and management using econometrics methods.
where can I find a legit pi merchant onlineDOT TECH
Yes. This is very easy what you need is a recommendation from someone who has successfully traded pi coins before with a merchant.
Who is a pi merchant?
A pi merchant is someone who buys pi network coins and resell them to Investors looking forward to hold thousands of pi coins before the open mainnet.
I will leave the telegram contact of my personal pi merchant to trade with
@Pi_vendor_247
USDA Loans in California: A Comprehensive Overview.pptxmarketing367770
USDA Loans in California: A Comprehensive Overview
If you're dreaming of owning a home in California's rural or suburban areas, a USDA loan might be the perfect solution. The U.S. Department of Agriculture (USDA) offers these loans to help low-to-moderate-income individuals and families achieve homeownership.
Key Features of USDA Loans:
Zero Down Payment: USDA loans require no down payment, making homeownership more accessible.
Competitive Interest Rates: These loans often come with lower interest rates compared to conventional loans.
Flexible Credit Requirements: USDA loans have more lenient credit score requirements, helping those with less-than-perfect credit.
Guaranteed Loan Program: The USDA guarantees a portion of the loan, reducing risk for lenders and expanding borrowing options.
Eligibility Criteria:
Location: The property must be located in a USDA-designated rural or suburban area. Many areas in California qualify.
Income Limits: Applicants must meet income guidelines, which vary by region and household size.
Primary Residence: The home must be used as the borrower's primary residence.
Application Process:
Find a USDA-Approved Lender: Not all lenders offer USDA loans, so it's essential to choose one approved by the USDA.
Pre-Qualification: Determine your eligibility and the amount you can borrow.
Property Search: Look for properties in eligible rural or suburban areas.
Loan Application: Submit your application, including financial and personal information.
Processing and Approval: The lender and USDA will review your application. If approved, you can proceed to closing.
USDA loans are an excellent option for those looking to buy a home in California's rural and suburban areas. With no down payment and flexible requirements, these loans make homeownership more attainable for many families. Explore your eligibility today and take the first step toward owning your dream home.
What website can I sell pi coins securely.DOT TECH
Currently there are no website or exchange that allow buying or selling of pi coins..
But you can still easily sell pi coins, by reselling it to exchanges/crypto whales interested in holding thousands of pi coins before the mainnet launch.
Who is a pi merchant?
A pi merchant is someone who buys pi coins from miners and resell to these crypto whales and holders of pi..
This is because pi network is not doing any pre-sale. The only way exchanges can get pi is by buying from miners and pi merchants stands in between the miners and the exchanges.
How can I sell my pi coins?
Selling pi coins is really easy, but first you need to migrate to mainnet wallet before you can do that. I will leave the telegram contact of my personal pi merchant to trade with.
Tele-gram.
@Pi_vendor_247
Turin Startup Ecosystem 2024 - Ricerca sulle Startup e il Sistema dell'Innov...Quotidiano Piemontese
Turin Startup Ecosystem 2024
Una ricerca de il Club degli Investitori, in collaborazione con ToTeM Torino Tech Map e con il supporto della ESCP Business School e di Growth Capital
how to sell pi coins in South Korea profitably.DOT TECH
Yes. You can sell your pi network coins in South Korea or any other country, by finding a verified pi merchant
What is a verified pi merchant?
Since pi network is not launched yet on any exchange, the only way you can sell pi coins is by selling to a verified pi merchant, and this is because pi network is not launched yet on any exchange and no pre-sale or ico offerings Is done on pi.
Since there is no pre-sale, the only way exchanges can get pi is by buying from miners. So a pi merchant facilitates these transactions by acting as a bridge for both transactions.
How can i find a pi vendor/merchant?
Well for those who haven't traded with a pi merchant or who don't already have one. I will leave the telegram id of my personal pi merchant who i trade pi with.
Tele gram: @Pi_vendor_247
#pi #sell #nigeria #pinetwork #picoins #sellpi #Nigerian #tradepi #pinetworkcoins #sellmypi
when will pi network coin be available on crypto exchange.DOT TECH
There is no set date for when Pi coins will enter the market.
However, the developers are working hard to get them released as soon as possible.
Once they are available, users will be able to exchange other cryptocurrencies for Pi coins on designated exchanges.
But for now the only way to sell your pi coins is through verified pi vendor.
Here is the telegram contact of my personal pi vendor
@Pi_vendor_247
when will pi network coin be available on crypto exchange.
Entrepreneurship 101: Hey buddy, can you spare a $100 million
1. hey buddy, can you spare
a $100 million?
or
how to convince
successful financiers to give you
millions of dollars in a project
doomed to fail!
Michael Polonsky
April 19th, 2006
2. I love love love
entrepreneurs life sciences canada
3. title here
generates long
high quality lasting, defined,
information effective, profitable
relationships
9. BREAK IN G T HR O UG H
FORTUNE MARCH 22, 2004
2
10. AF Incidence
arrhythmias 1 in 4 adults will get AF (age 40+)
6 million
patients in the world
Annual incidence: 700,000 * Wang et al. Circulation: Journal of the
American Heart Association. August 2004.
12. BREAK IN G T HR O UG H
50 YEAR CANCER BARRIER
Age-adjusted death rates per 100,000-population
600
500
Heart disease
400
300
200
Cancer
100
0
1950 1960 1970 1980 1990 2002
FORTUNE CHART/SOURCES CDC
3
13. World’s Largest Drug Market
Top 3 drug categories 2004 annual sales
$30.2B
}
$25.5B
5 blockbuster
drugs
$23.8B
Cytostatics Antiulcerants Cholesterol &
(Cancer) (GI tract) triglyceride
reducers
14. Current treatment drawbacks
drugs heat ablation
treats symptoms only used in <3% of cases
only when drugs fail
high procedural risks:
30 – 60% effectiveness
PV stenosis
diminishes over time
Thrombosis
Esophageal perforation
serious side effects
15. Healthcare ramifications and risks
leading cause of stroke >15%
1
2 leads to chronic heart failure >20%
3 leading cause of hospitalizations 415,000 (U.S.)
4 cost to healthcare US$6.6 billion
no practical solution!
* Donald M Lloyd-Jones, Md, ScM, FACC.
Medscape Cardiology 8 (2). 2004.
16. the billion dollar slide
No one invests in hyper growth stories to double their money
“you have to show them the 10 bagger”
- Michael Denny
17. BREAK IN G T HR O UG H
Theralux Market Opportunity
TM
current expected paradigm market
$140 M $126 M $3 B
Blood disorders
aGvHD current AlloSCT
Solid tumours with GVT
aGvHD other cancers
Autoimmune life-threatening
17
18. BREAK IN G T HR O UG H
NB1011 Market Opportunity
Initial Market Paradigm Shift
End Stage First Line Treatment (with TS over expression)
$1.0B $4.7B
Lung (NSCLC) Lung (NSCLC)
Breast Breast
Stomach Stomach
Small bowel Small bowel
Ovarian Ovarian
Bladder Bladder
Colorectal Colorectal
High TS patient
25
20. AF Business Opportunity
Untreated Pool New Cases/Year
2.2 million 160,000
>$2 Billion
Annual Business Opportunity
2.1 million 145,000
4.3 million 305,000
21. at last, your passion…
value
value
proposition
“if only they understood me”
solution to hunger
23. Our Customers: Leading U.S. Hospitals
Our Advanced Neuro-Diagnostic Instruments are used in over 1,300
hospitals in the United States including 6 of the top 10 Neurology and
Neurosurgery Hospitals
23
24. Positive Phase I Results
Safety and • 3 phase I trials
• Single and multiple dose
tolerability • 65 healthy volunteers
established • Blood chemistry within
normal ranges
• No reported significant
adverse events
25. CRD5 Rapidly Increases HDL
% increase in HDL
CRD5 Niacin - ER
Levels still rising Poorly tolerated
Non-optimized Low market share
formulation
Healthy volunteers
Crestor
(Statin)
26. Arctic Front: Encouraging early results
20 patients / 2 centers (rev 1)
> 84% AF free
> 95% reduced burden & AF free
75 patients / 6 centers (rev 2)
> 98% acute success
no safety concerns!
27. Neuradiab
60million
$
1.
MATURE
R&D invested by NIH grant
/ foundation funding
PRODUCT
7trials
CANDIDATE 2.
Progressive survival
benefit demonstrated
193 patients
3.
Established safety profile 27
28. Neuradiab Outcomes
Clinically compelling difference
42 %
Increase in survival =
91
Surgery + Radiation + Temozolomide + Neuradiab
weeks
2005 Surgery + Radiation + Temozolomide
1980
Surgery + Radiation
to
2004
0 15 30 45 60 75 90 105
Survival in weeks 28
29. competitive landscape
be honest/humble - don’t be cavalier
In all likelihood, the person across from you
a) has an opinion
b) knows more than you
respect other interpretations of the truth
30. Competitive Landscape - Surgical
Only 1 of “big 5” in the game today Only 1 start-up in the game
Medtronic (30-35%) AtriCure (20-25%)
bipolar (RF) bipolar (RF)
BSx (10-15%)
unipolar (RF)
Guidant (10%)
CryoCath
AFX (Microwave)
15-20%
St.Jude (pre-commercial)
Epicor (HIFU)
J&J
no initiative
32. Milestones
SPY System Q3 2005 Q4 2005 Q1 2006
X
U.S. sales partner
X
Installed in 25 U.S. hospitals
X
Initiate studies for expanded indications
OPTTX System
X
Initiate North American multi-centre trial
X
Initiate combo trial with multi-national partner
X
File for Canadian and European approval
33. Investment Opportunity
Seeking – Launching
commercial platform
$15million – Expanding content
partnerships
in financing
– Developing
to drive the molecular tests
business – Scaling quality
forward manufacturing
34. Financing History & Shareholders
Date Amount Type Shareholders
April 2001 C$21M Series A • MDS Capital
Preferred Shares • Covington Capital
• Genesys
• Temple Ridge
• Management
December 2003 C$5M Convertible • MDS Capital
Subordinated Debt • Covington Capital
TOTAL C$26M
34